Table 3

Airway wall area according to COPD status stratified by lumen diameter strata in SPIROMICS and the MESA COPD study

MESA COPDLumen diameter strata in mm
>11.5>10.0 to 11.5>8.5 to 10.0>7.0 to 8.5>5.5 to 7.0>4.0 to 5.5>2.5 to 4.0
Unadjusted mean airway wall area in mm2
 COPD149.796.481.165.550.935.120.4
 No COPD144.492.678.562.046.832.719.7
 Difference (95% CI)
 p Value
5.3 (−0.2 to 10.9)
0.06
3.8 (−0.6 to 8.4)
0.09
2.6 (−0.1 to 5.5)
0.06
3.5 (1.6 to 5.5)
<0.001
4.1 (2.9 to 5.4)
<0.001
2.4 (1.6 to 3.2)
<0.001
0.7 (0.4 to 1.1)
<0.001
Mean airway wall area in mm2 adjusted for age, gender, height, race-ethnicity, smoking status, airway length, per cent emphysema−950HU, BMI-determined CT dose, and lung volume at CT
 COPD141.993.678.264.950.634.922.0
 No COPD147.193.878.162.546.832.721.6
 Difference (95% CI)
 p Value
−5.2 (−10.1 to −0.2)
p=0.04
−0.2 (−4.4 to 4.3)
p=0.9426
0.1 (−2.7 to 3.0)
p=0.96
2.3 (0.5 to 4.2)
p=0.01
3.8 (2.5 to 5.2)
p<0.001
2.2 (1.3 to 3.0)
p<0.001
0.4 (0.1 to 0.7)
p=0.003
Lumen diameter strata in mm
SPIROMICS>11.5>10.0 to 11.5>8.5 to 10.0>7.0 to 8.5>5.5 to 7.0>4.0 to 5.5>2.5 to 4.0
Unadjusted mean airway wall area in mm2
 COPD150.896.378.863.148.733.918.8
 No COPD145.694.177.661.646.232.118.6
 Difference (95% CI)
 p Value
5.2 (2.5 to 8.0)
<0.001
2.2 (−0.3 to 4.6)
0.08
1.2 (−0.2 to 2.7)
0.09
1.5 (0.5 to 2.4)
0.003
2.5 (1.8 to 3.2)
<0.001
1.7 (1.4 to 2.1)
<0.001
0.3 (0.1 to 0.5)
<0.001
Mean airway wall area in mm2 adjusted for age, gender, height, race-ethnicity, smoking status, airway length, per cent emphysema−950HU, BMI-determined CT dose, and lung volume at CT
 COPD145.695.078.062.848.733.618.9
 No COPD146.194.578.262.847.032.218.6
 Difference (95% CI)
 p Value
−0.5 (−3.5 to 2.5)
p=0.74
0.6 (−2.1 to 3.3)
p=0.68
−0.2 (−1.8 to 1.3)
p=0.77
0.0 (−1.1 to 1.0)
p=0.97
1.7 (0.9 to 2.5)
p<0.001
1.4 (1.0 to 1.8)
p<0.001
0.2 (0.1 to 0.4)
p=0.01
  • Mean values and differences, along with 95% CI and p values were estimated using linear regression with generalised estimating equations.

  • BMI, body mass index; HU, Hounsfield units; MESA, Multi-Ethnic Study of Atherosclerosis; SPIROMICS Subpopulations and Intermediate Outcome Measures in COPD Study.